We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Latent Toxoplasmosis Prevalence Analyzed Retrospectively

By LabMedica International staff writers
Posted on 01 Sep 2016
Primary maternal infection with Toxoplasma gondii during pregnancy can lead to prenatal infection of the unborn child, and vertical diaplacental transmission of Toxoplasma can seriously damage the embryo. More...
Some prenatally infected children, asymptomatic at birth, can develop retinochorioiditis and other sequelae months or years later.

In Austria, mandatory screening for the prevention of congenital toxoplasmosis stipulates a serological test for antibodies against T. gondii as early as possible in pregnancy. In the case of a seronegative result, subsequent tests at intervals of eight weeks are requested. If antibodies against the parasites are detected, the sample is further tested for specific immunoglobulin M (IgM) antibodies. A negative IgM report indicates a late latent infection that poses no threat for the current pregnancy.

A team of scientists collaborating with the Labor Dr. Berghold (Graz, Austria) analyzed serological data from Styria, an Austrian federal state, to determine the sero-prevalence and incidence of Toxoplasma infections. The study included 353,599 tests from 103,316 women during 158,571 pregnancies from 1995 to 2012.

Three different test systems were used to screen for antibodies against T. gondii: from January 1, 1995, to June 18, 2006, the team used slides coated with T. gondii for indirect immunofluorescence test (IIFT). From June 19, 2006, to December 5, 2010, the determinations were made with the automated Vidas Toxo IgG System (bioMérieux, Marcy-l'Étoile, France). Since December 6, 2010, Toxoplasma IgG has been determined automatically using the Architect System (Abbott Diagnostics, Lake Forest, IL, USA). Toxoplasma IgM test to confirm seroconversion was determined with the following systems: the automated bioMérieux Vidas Toxo IgM System; the bioMérieux automated Vidia IgM assay; and since December 6, 2010, the automated Architect System IgM assay from Abbott Diagnostics.

The scientists found that the age-adjusted sero-prevalence decreased from 43.3% in 1995 to 31.5% in 2012, with a yearly decline of 0.84%. The intergravid incidence showed an annual decrease of 4.2%. The average yearly incidence of intragravid and intergravid seroconversions was 0.52% and 0.72%, respectively. Therefore it is to be expected that the sero-prevalence of latent Toxoplasma infections will continue to show a clear decrease. That means, however, that the number of women of childbearing age who are at risk of infection will increase. The net effect is that although primary infections in pregnancy are decreasing, prenatal toxoplasmosis will continue to pose a substantial threat to pregnant women and their children.

The main source of human Toxoplasma infections is seen to be consumption of undercooked meat and meat products. Modern technology in meat processing may have reduced the degree of contamination, and hygiene measures such as strict rodent control and cats in livestock barns help to reduce infection pressure. Deep-freezing meat for a number of days also helps to kill T. gondii. For some years, however, there has been a trend towards organic and free-range farming, and in such operations, there is a higher sero-prevalence of infection. The study was published on August 18, 2016, in the journal Eurosurveillance.

Related Links:
Labor Dr. Berghold
bioMérieux
Abbott Diagnostics

New
Gold Member
Ketosis and DKA Test
D-3-Hydroxybutyrate (Ranbut) Assay
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Homocysteine Quality Control
Liquichek Homocysteine Control
Gold Member
Hybrid Pipette
SWITCH
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Scout\'s patented molecular technology delivers results matching high-complexity PCR 99% of the time (Photo courtesy of Scout Health)

STI Molecular Test Delivers Rapid POC Results for Treatment Guidance

An affordable, rapid molecular diagnostic for sexually transmitted infections (STIs) has the potential to be globally relevant, particularly in resource-limited settings where rapid, point-of-care results... Read more

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: Determining EG spiked into medicinal syrups: Zoomed-in images of the pads on the strips are shown. The red boxes show where the blue color on the pad could be seen when visually observed (Arman, B.Y., Legge, I., Walsby-Tickle, J. et al. https://doi.org/10.1038/s41598-025-26670-1)

Rapid Low-Cost Tests Can Prevent Child Deaths from Contaminated Medicinal Syrups

Medicinal syrups contaminated with toxic chemicals have caused the deaths of hundreds of children worldwide, exposing a critical gap in how these products are tested before reaching patients.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.